info@synchemia.com | sales@synchemia.com 
9766925136 
Brexpiprazole Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brexpiprazole is used to treat mental conditions, including depression and schizophrenia. It is also used to treat agitation that may happen with dementia caused by Alzheimer's disease. Brexpiprazole is an antipsychotic agent. It works in the brain to change how certain chemicals affect patients . Brexpiprazole Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brexpiprazole Nitroso Impurity 1 chemically represented as 1-(Benzo[b]thiophen-4-yl)-4-nitrosopiperazine.Synchemia is the leading manufacturing and exporter of Brexpiprazole Nitroso Impurity 1. We supply Brexpiprazole Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0143794 |
| CAS No | NA |
| Mol.F. | C21H18D5N5O3S |
| Mol.Wt. | 430.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143795 |
| CAS No | 1219794-54-3 |
| Mol.F. | C4D10N2O |
| Mol.Wt. | 112.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143796 |
| CAS No | NA |
| Mol.F. | C8H7F3N4O5S2 |
| Mol.Wt. | 360.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143797 |
| CAS No | NA |
| Mol.F. | C15H16N2O4 |
| Mol.Wt. | 288.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143798 |
| CAS No | NA |
| Mol.F. | C15H18N2O4 |
| Mol.Wt. | 290.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143799 |
| CAS No | 2639422-25-4 |
| Mol.F. | C10H19N3O |
| Mol.Wt. | 197.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143800 |
| CAS No | NA |
| Mol.F. | C8H14N2O5 |
| Mol.Wt. | 218.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143801 |
| CAS No | NA |
| Mol.F. | C8H15N3O4 |
| Mol.Wt. | 217.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143802 |
| CAS No | NA |
| Mol.F. | C8H14ClN3O3 |
| Mol.Wt. | 235.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143803 |
| CAS No | NA |
| Mol.F. | C17H9D8FN4O5 |
| Mol.Wt. | 384.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143804 |
| CAS No | NA |
| Mol.F. | C34H39N7O7 |
| Mol.Wt. | 657.7 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143805 |
| CAS No | NA |
| Mol.F. | C12H12D5N3O2 |
| Mol.Wt. | 240.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143806 |
| CAS No | NA |
| Mol.F. | C10H19D4N3O3 |
| Mol.Wt. | 237.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143807 |
| CAS No | NA |
| Mol.F. | C10H18D4N4O4 |
| Mol.Wt. | 266.3 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143808 |
| CAS No | NA |
| Mol.F. | C10H22N215N2O4 |
| Mol.Wt. | 264.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143809 |
| CAS No | NA |
| Mol.F. | C10H23N215NO3 |
| Mol.Wt. | 234.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
